Interim Chief Accounting Officer @ (April 2025 - December 2025)
Chief Financial Officer and Chief Business Officer @ (July 2024 - April 2025)
Chief Financial Officer @ (August 2022 - April 2025)
Vice President Finance @ (January 2022 - July 2022)
Head of Commercial Finance Mylan Institutional @ (October 2017 - January 2022)
Director Mylan Institutional Commercial Finance @ (December 2014 - December 2017)
Director North America Commercial Finance (Mylan) @ (March 2014 - December 2014)
Senior Manager - General Accounting (Mylan) @ (December 2012 - March 2014)
Director of Global Accounting and Financial Reporting @ Taggart Global, LLC (September 2006 - October 2012)
Team Leader Corporate Financial Planning and Reporting @ (August 2000 - September 2006)
Audit Manager @ Guthrie Belczyk & Associates, PC (November 1998 - August 2000)
Controller @ Smith Machine (January 1997 - January 1998)
CFO and Controller @ UCP of Southwestern Pennsylvania (January 1996 - January 1997)
Audit Senior @ Taggart Mitchell & Associates PC (January 1993 - January 1996)
Wade Smith Education
Duke University - The Fuqua School of Business
Advanced Leadership Program in Health Sector
2025-2025
PennWest California
Bachelor of Science (BS) (Accounting and Business/Management)
1988-1992
Wade Smith Skills
Corporate Development
New Business Development
Initial Public Offerings (IPO)
Process Improvement
Financial Reporting
Finance
Accounting
Leadership
Auditing
Corporate Finance
Financial Analysis
Forecasting
Business Strategy
Financial Accounting
Variance Analysis
Cash Flow
Business Process Improvement
Investor Relations
Certified Public Accountant
CPA
Strategic Planning
Budgeting
SAP Products
Management
Financial Forecasting
Negotiation
Team Leadership
Business Development
Financial Modeling
Treasury
Build Strong Relationships
Capital Markets
Cash Management
Channel Strategy
Commercial Operation
Consumer Packaged Goods (CPG)
Direct Market Access
ERP Implementations
Executive Team
Financial Consolidation
Financial Operations
Financial Oversight
Financial Planning and Analysis (FP&A)
Financial Regulations
Government Pricing
Internal Control Implementation
International Tax Planning
Legal Contract Negotiation
Licensing
Market Access
Marketing
Mergers & Acquisitions (M&A)
New Market Expansion
Pricing Strategy
Problem Solving
Product Forecasting
Product Launch
Public Companies
Risk Management
Sales Operations
Strategic Growth
Strategic Leadership
Supply Chain Management
Turnaround Experience
Wade Smith Summary
Wade Smith, based in United States, is currently a Interim Chief Executive Officer at Herald Therapeutics. Wade Smith brings experience from previous roles at Herald Therapeutics, Voyager Holdings II, LLC, Conair LLC and Elevar Therapeutics. Wade Smith holds a 2025 - 2025 Advanced Leadership Program in Health Sector @ Duke University - The Fuqua School of Business. With a robust skill set that includes Corporate Development, New Business Development, Initial Public Offerings (IPO), Process Improvement, Financial Reporting and more. Wade Smith has 3 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Wade Smith?
Find contact details for 700 million professionals.